There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...

Carl Zeiss Meditec has strong fundamentals and growth potential. It has impressive free cash flow and rising shareholder ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...

EQS-News: Carl Zeiss Meditec AG / Key word (s): Annual Report/Annual Results Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved 11.12.2024 ...

View Carl Zeiss Meditec AG (CZMWY) current and estimated P/E ratio data provided by Seeking Alpha.

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...

It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...